Search research articles
Contact Us
Filters
Showing results (771-780 of 1,095) with videos related to
Page
of 110
Sort By:
Scientific Reports
|
September 13, 2019
Enamel peptides reveal the sex of the Late Antique 'Lovers of Modena'
Federico Lugli, Giulia Di Rocco, Antonino Vazzana, et al.
Hepatology (Baltimore, Md.)
|
May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological response
Roeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
Targeted Oncology
|
August 2, 2021
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study
Matteo Santoni, Francesco Massari, Enrique Grande, et al.
JHEP Reports : Innovation in Hepatology
|
December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection
Nicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
Nature Communications
|
September 20, 2018
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis
Grigory Ryzhakov, Nathaniel R West, Fanny Franchini, et al.
Journal of Gastroenterology and Hepatology
|
January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals
Sergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.
European Journal of Gastroenterology & Hepatology
|
December 22, 2018
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Emilio Suárez, María Buti, Manuel Rodríguez, et al.
Targeted Oncology
|
January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
Matteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
World Journal of Gastroenterology
|
December 10, 2021
Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?
Selene Garcia-Garcia, Maria Francesca Cortese, David Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2019
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
Ugo De Giorgi, Giuseppe Procopio, Diana Giannarelli, et al.
Page
of 110
Search research articles
Search
Showing results (771-780 of 1,095) with videos related to
Sort By:
Page
of 110
Scientific Reports
|
September 13, 2019
Enamel peptides reveal the sex of the Late Antique 'Lovers of Modena'
Federico Lugli, Giulia Di Rocco, Antonino Vazzana, et al.
Hepatology (Baltimore, Md.)
|
May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological response
Roeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
Targeted Oncology
|
August 2, 2021
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study
Matteo Santoni, Francesco Massari, Enrique Grande, et al.
JHEP Reports : Innovation in Hepatology
|
December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection
Nicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
Nature Communications
|
September 20, 2018
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis
Grigory Ryzhakov, Nathaniel R West, Fanny Franchini, et al.
Journal of Gastroenterology and Hepatology
|
January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals
Sergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.
European Journal of Gastroenterology & Hepatology
|
December 22, 2018
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Emilio Suárez, María Buti, Manuel Rodríguez, et al.
Targeted Oncology
|
January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
Matteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
World Journal of Gastroenterology
|
December 10, 2021
Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?
Selene Garcia-Garcia, Maria Francesca Cortese, David Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2019
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
Ugo De Giorgi, Giuseppe Procopio, Diana Giannarelli, et al.
Page
of 110